NCT07029542View on ClinicalTrials.gov

Home Reported Outcomes in C3G Study

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 7, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
C3 Glomerulopathy
Trial Locations (1)

07936

RECRUITING

Novartis Investigative Site, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY